Revenue | ₹169.34Cr |
Net Profits | ₹27.68Cr |
Net Profit Margins | 16.35% |
Lincoln Pharmaceuticals Ltd’s revenue jumped 7.39% since last year same period to ₹169.34Cr in the Q1 2025-2026. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 4.98% jump in its revenue since last 3-months.
Lincoln Pharmaceuticals Ltd’s net profit jumped 16.94% since last year same period to ₹27.68Cr in the Q1 2025-2026. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 139.03% jump in its net profits since last 3-months.
Lincoln Pharmaceuticals Ltd’s net profit margin jumped 8.9% since last year same period to 16.35% in the Q1 2025-2026. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 127.68% jumped in its net profit margins since last 3-months.
The revenue for Lincoln Pharmaceuticals Ltd in the Q1 results 2025 was ₹169.34Cr.
The net profit for Lincoln Pharmaceuticals Ltd in the Q1 results 2025 was ₹27.68Cr.
The net profit margin for Lincoln Pharmaceuticals Ltd in the Q1 results 2025 was 16.35%.
The revenue for Lincoln Pharmaceuticals Ltd in the Q1 results 2024 was ₹157.69Cr.
The net profit for Lincoln Pharmaceuticals Ltd in the Q1 results 2024 was ₹23.67Cr.
The net profit margin for Lincoln Pharmaceuticals Ltd in the Q1 results 2024 was 15.01%.